Back
Biomarin Pharmaceutical Stock Price Chart
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Buy
60
BMRN
Biomarin Pharmaceutical
Last Price:
$65.65
Seasonality Move:
5.39%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.79 | Sell |
| 20-day SMA: | 65.64 | Buy |
| 50-day SMA: | 66.69 | Sell |
| 200-day SMA: | 78.92 | Sell |
| 8-day EMA: | 65.67 | Buy |
| 20-day EMA: | 65.74 | Sell |
| 50-day EMA: | 67.62 | Sell |
| 200-day EMA: | 77.02 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 48.8 | Sell |
| Chaikin Money Flow: | 1709604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.56 - 66.54) | Buy |
| Bollinger Bands (100): | (64.13 - 84.07) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 65.69 while BMRN 8-day simple moving average is 65.79, which is a Sell signal.
-
The stock price of BMRN is 65.69 while Biomarin Pharmaceutical 20-day SMA is 65.64, which makes it a Buy.
-
Biomarin Pharmaceutical 50-day simple moving average is 66.69 while BMRN share price is 65.69, making it a Sell technically.
-
BMRN stock price is 65.69 and Biomarin Pharmaceutical 200-day simple moving average is 78.92, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a BuyThe current Biomarin Pharmaceutical [BMRN] share price is $65.69. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
12.5B
Price in USD:
65.69
Share Volume:
3.6M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.25
52-Week Low:
61.15
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?The Biomarin Pharmaceutical stock price is 65.69 USD today.
-
Will BMRN stock go up or go down?Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Biomarin Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 65.69 while BMRN 8-day exponential moving average is 65.67, which is a Buy signal.
-
The stock price of BMRN is 65.69 while Biomarin Pharmaceutical 20-day EMA is 65.74, which makes it a Sell.
-
Biomarin Pharmaceutical 50-day exponential moving average is 67.62 while BMRN share price is 65.69, making it a Sell technically.
-
BMRN stock price is 65.69 and Biomarin Pharmaceutical 200-day simple moving average is 77.02, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting Biomarin Pharmaceutical is a Sell
-
Biomarin Pharmaceutical Relative Strength Index (RSI) is 48.8, which suggest Biomarin Pharmaceutical is oversold
-
The Bollinger Bands (25) for Biomarin Pharmaceutical is (63.56 - 66.54), which suggest Biomarin Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Biomarin Pharmaceutical is (64.13 - 84.07), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.